PPAR α/γ Agonist in Management of Diabetic Dyslipidemia: A Review

Abstract

Cardiovascular diseases are major contributors of mortality and morbidity in patients with type 2 diabetes mellitus (T2DM), while dyslipidemia and hyperglycemia are key modifiable risk factors to prevent coronary artery disease (CAD). Although healthy diet, regular physical activity and maintaining a normal body weight are advised, patients generally require single or multiple drugs to treat T2DM. Moreover, patients with T2DM are prone to atherogenic diabetic dyslipidemia (ADD), which is characterized by elevated triglyceride, small dense LDL particles and low High-density lipoprotein (HDL) cholesterol. Even though low-density lipoprotein cholesterol (LDL) remains the primary target of therapy, non-high density lipoprotein (non-HDL) cholesterol is as an important parameter to be considered in clinical practice. Unfortunately, high-dose statin therapy is not advised for long term, as it can increase risk of new onset T2DM. On the other hand, glitazars are newer molecules having dual peroxisome proliferator-activated receptors (PPAR) α/γ agonistic action that can improve lipid profile with improvement of insulin sensitivity. In conclusion, the overall safety of saroglitazar is acceptable due to minimal side effects, but improvement of β cell function, effect on insulin sensitivity by analysis of insulin resistance index by using the homeostatic model assessment (HOMAIR) and long term cardiovascular benefits like atherosclerotic plaque stabilization or regression need to be confirmed.

Authors and Affiliations

Radhika A. Vaishnav

Keywords

Related Articles

Population Pharmacokinetic Analysis of Alcohol Concentration after Beer Consumption in Fasted Japanese Subjects

The absorption rate of alcohol is one of the determinants of the peak blood alcohol concentration. Studies focusing on factors that cause inter-individual variability in absorption rate have not been conducted. To conduc...

Forensic Relevance of The Suicide Tree “Cerebra Odollam”

Cerbera odollam is a powerful toxic plant that is responsible both for suicide and homicide. The seeds are excessively toxic, containing cerberin as the main active cardenolide. Cerberin is difficult to detect in autopsi...

The Discovery of Insulin and the Future for Insulin Replacement Therapy

Adequate consumption of antioxidants, such as vitamin E, is thought to be essential for optimal health. Nutritional surveys have shown below optimal levels of vitamin E intake for adults in the United States despite a va...

Decomposition of Concentration-Time Profiles after Oral Administration of Different Ethanol Doses in Humans

A new physiologically-motivated structural model capable of evaluating ethanol behavior within the whole-body blood metabolism was developed. This model was estimated on the basis of a reanalysis of the mean blood ethano...

Further Development of Beauchamp and Childress’ Theory Based on Empirical Ethics

The American ethicists Tom L. Beauchamp and James F. Childress developed a framework of four ethical principles which are useful to analyze ethical complex cases in biomedicine. These four principles are respect for auto...

Download PDF file
  • EP ID EP201713
  • DOI 10.19070/2167- 910X-1500026
  • Views 97
  • Downloads 0

How To Cite

Radhika A. Vaishnav (2015). PPAR α/γ Agonist in Management of Diabetic Dyslipidemia: A Review. International Journal of Clinical Pharmacology & Toxicology(IJCPT), 4(1), 143-149. https://europub.co.uk/articles/-A-201713